Andrea Spencer, MD is an Assistant Professor of Psychiatry at the Chobanian and Avedisian School of Medicine. Her primary research interest is improving treatment for ADHD in primary care settings. She is Board Certified in both Child and Adult Psychiatry after completing a dual residency at Mass General Hospital and McLean Hospital. She stayed at Mass General Hospital to work with Dr. Joseph Biederman in the Bressler Program for Autism at MGH. Dr. Spencer’s research has been bolstered by grants such as the Dupont Warren and Livingston Awards. Outside of the medical field Dr. Spencer, a music major during her undergrad, plays viola with the Longwood Symphony Orchestra.
- Harvard Medical School, MD
- Yale University, BA
- Published on 1/1/2019
Surman C, Ceranoglu A, Vaudreuil C, Albright B, Uchida M, Yule A, Spencer A, Boland H, Grossman R, Rhodewalt L, Fitzgerald M, Biederman J. Does L-Methylfolate Supplement Methylphenidate Pharmacotherapy in Attention-Deficit/Hyperactivity Disorder?: Evidence of Lack of Benefit From a Double-Blind, Placebo-Controlled, Randomized Clinical Trial. J Clin Psychopharmacol. 2019 Jan/Feb; 39(1):28-38. PMID: 30566416.
- Published on 1/1/2019
Spencer AE, Chiang C, Plasencia N, Biederman J, Sun Y, Gebara C, Jellinek M, Murphy JM, Zima BT. Utilization of Child Psychiatry Consultation Embedded in Primary Care for an Urban, Latino Population. J Health Care Poor Underserved. 2019; 30(2):637-652. PMID: 31130542.
- Published on 7/13/2018
Spencer AE, Plasencia N, Sun Y, Lucke C, Haile H, Cronin R, Faraone SV, Jellinek M, Murphy JM, Biederman J. Screening for Attention-Deficit/Hyperactivity Disorder and Comorbidities in a Diverse, Urban Primary Care Setting. Clin Pediatr (Phila). 2018 10; 57(12):1442-1452. PMID: 30003797.
- Published on 3/1/2018
Spencer TJ, Bhide P, Zhu J, Faraone SV, Fitzgerald M, Yule AM, Uchida M, Spencer AE, Hall AM, Koster AJ, Feinberg L, Kassabian S, Storch B, Biederman J. The Mixed Opioid Receptor Antagonist Naltrexone Mitigates Stimulant-Induced Euphoria: A Double-Blind, Placebo-Controlled Trial of Naltrexone. J Clin Psychiatry. 2018 Mar/Apr; 79(2). PMID: 29617066.
- Published on 1/1/2018
Spencer TJ, Bhide P, Zhu J, Faraone SV, Fitzgerald M, Yule AM, Uchida M, Spencer AE, Hall AM, Koster AJ, Biederman J. Opiate Antagonists Do Not Interfere With the Clinical Benefits of Stimulants in ADHD: A Double-Blind, Placebo-Controlled Trial of the Mixed Opioid Receptor Antagonist Naltrexone. J Clin Psychiatry. 2018 Jan/Feb; 79(1). PMID: 28640990.
- Published on 6/29/2017
Wilens TE, Carrellas NW, Zulauf C, Yule AM, Uchida M, Spencer A, Biederman J. Pilot Data Supporting Omega-3 Fatty Acids Supplementation in Medicated Children with Attention-Deficit/Hyperactivity Disorder and Deficits in Emotional Self-Regulation. J Child Adolesc Psychopharmacol. 2017 10; 27(8):755-756. PMID: 28661708.
- Published on 6/1/2017
Uchida M, Spencer AE, Kenworthy T, Chan J, Fitzgerald M, Rosales AM, Kagan E, Saunders A, Biederman J. A Pilot Study: Cardiac Parameters in Children Receiving New-Generation Antidepressants. J Clin Psychopharmacol. 2017 Jun; 37(3):359-362. PMID: 28301398.
- Published on 2/10/2017
Spencer AE, Marin MF, Milad MR, Spencer TJ, Bogucki OE, Pope AL, Plasencia N, Hughes B, Pace-Schott EF, Fitzgerald M, Uchida M, Biederman J. Abnormal fear circuitry in Attention Deficit Hyperactivity Disorder: A controlled magnetic resonance imaging study. Psychiatry Res. 2017 Apr 30; 262:55-62. PMID: 28235692.
- Published on 2/1/2017
Zaccagnino M, Gahagan S, Spencer A, Jellinek M, Stein MT. Sudden Onset of Refusal to Eat on Waking After a Nightmare in a 6-Year-Old Girl. J Dev Behav Pediatr. 2017 Feb/Mar; 38 Suppl 1:S53-S55. PMID: 28141722.
- Published on 9/1/2016
Spencer AE, Biederman J. Drs Spencer and Biederman Reply. J Clin Psychiatry. 2016 09; 77(9):e1150. PMID: 27780324.
View 8 more publications: View full profile at BUMC